학술논문
Transparency in reporting of phase 3 cancer clinical trial results.
Document Type
Article
Source
Subject
*CHI-squared test
*ONCOLOGY
*REPORT writing
*SERIAL publications
*STATISTICS
*MULTIPLE regression analysis
*RANDOMIZED controlled trials
*PERIODICAL articles
*IMPACT factor (Citation analysis)
*DATA analysis software
*DESCRIPTIVE statistics
*MANN Whitney U Test
*RESEARCH protocols
*STANDARDS
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0284-186X
Abstract
In the article, the authors present their study to examine the transparency in the reporting of phase three cancer clinical trial results to support the efficacy of a specific therapy/intervention. In the research, the effects of protocol availability and completeness on transparent reporting are analyzed. Data from ClinicalTrials.gov were used to examine the trials' primary endpoint (PEP) results.